Page 11234..1020..»

Category Archives: Cancer Genetics

Cancer Genetics Expert Katherine L. Nathanson, MD, Named Deputy Director of Abramson Cancer Center – Newswise (press release)

Posted: August 18, 2017 at 12:44 pm

Newswise PHILADELPHIA Katherine L. Nathanson, MD, an internationally recognized expert in the field of cancer genetics, has been named deputy director of the Abramson Cancer Center of the University of Pennsylvania. Nathanson is a professor of Translational Medicine and Human Genetics in the Perelman School of Medicine, and the associate director for Population Sciences in the Abramson Cancer Center, co-leader of the Cancer Control Program, and Chief Oncogenomics Physician Continue reading



Source Link(s) Are Here

Cancer Genetics Expert Katherine L. Nathanson, MD, Named Deputy Director of Abramson Cancer Center - Newswise (press release)

Posted in Cancer Genetics | Comments Off on Cancer Genetics Expert Katherine L. Nathanson, MD, Named Deputy Director of Abramson Cancer Center – Newswise (press release)

ETMC Cancer Institues hosts women’s luncheon – cbs19.tv

Posted: at 12:44 pm

Gabriela Garcia, KYTX 10:02 AM. Continue reading



Source Link(s) Are Here

ETMC Cancer Institues hosts women's luncheon - cbs19.tv

Posted in Cancer Genetics | Comments Off on ETMC Cancer Institues hosts women’s luncheon – cbs19.tv

Cancer Genetics pays $12M for Australian CRO vivoPharm – FierceBiotech

Posted: at 12:44 pm

U.S. oncology specialist Cancer Genetics will pay $12 million to buy out Australian contract research organization vivoPharm as it looks to bolster its offerings. Cancer Genetics (CGI) says the deal will boost its position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies Continue reading



Source Link(s) Are Here

Cancer Genetics pays $12M for Australian CRO vivoPharm - FierceBiotech

Posted in Cancer Genetics | Comments Off on Cancer Genetics pays $12M for Australian CRO vivoPharm – FierceBiotech

Cancer Genetics, Inc. (CGIX) has a value of $3.30 per share While AAC Holdings, Inc. (AAC) is stand at $8.78 – Stocks Gallery

Posted: at 12:44 pm

Cancer Genetics, Inc. (CGIX) Snapshot: In latest trading activity; Cancer Genetics, Inc. (CGIX) snatched the consideration from Investors, when its current beneficial picture was seen that is promoting good health. Continue reading



Source Link(s) Are Here

Cancer Genetics, Inc. (CGIX) has a value of $3.30 per share While AAC Holdings, Inc. (AAC) is stand at $8.78 - Stocks Gallery

Posted in Cancer Genetics | Comments Off on Cancer Genetics, Inc. (CGIX) has a value of $3.30 per share While AAC Holdings, Inc. (AAC) is stand at $8.78 – Stocks Gallery

Increased Confidence Earns Myriad Genetics An Upgrade – Benzinga

Posted: at 12:44 pm

Deutsche Bank upgraded Myriad Genetics, Inc. Continue reading



Source Link(s) Are Here

Increased Confidence Earns Myriad Genetics An Upgrade - Benzinga

Posted in Cancer Genetics | Comments Off on Increased Confidence Earns Myriad Genetics An Upgrade – Benzinga

Putting Cancer Genetics Inc (CGIX) Under the Microscope: Technicals Watch – Stock Daily Review

Posted: August 15, 2017 at 3:42 am

Needle moving action has been spotted in Cancer Genetics Inc (CGIX) as shares are moving today onvolatility3.28% or $0.12 from the open.TheNASDAQ listed companysaw a recent bid of $3.78 and32927shares have traded hands in the session. Doing the necessary homework, investors have a wealth of information about publically traded stocks. Figuring out which ones are going to steadily outperform can be a tricky task. Continue reading



Source Link(s) Are Here

Putting Cancer Genetics Inc (CGIX) Under the Microscope: Technicals Watch - Stock Daily Review

Posted in Cancer Genetics | Comments Off on Putting Cancer Genetics Inc (CGIX) Under the Microscope: Technicals Watch – Stock Daily Review

Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes – Zacks.com

Posted: at 3:42 am

On Aug 11, we issued an updated research report on Salt Lake City, UT-based molecular diagnostics provider,Myriad Genetics, Inc.(MYGN – Free Report). The company currently carries a Zacks Rank #3 (Hold). Continue reading



Source Link(s) Are Here

Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes - Zacks.com

Posted in Cancer Genetics | Comments Off on Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes – Zacks.com

Chartists Taking Aim at Cancer Genetics Inc (CGIX) Shares – Evergreen Caller

Posted: at 3:42 am

Shares ofCancer Genetics Inc (CGIX) are on watch as the Tenkan Line has moved belowthe Kijun line, indicating negative momentum for the equity. Cancer Genetics Inc moved0.05 in the most recent session and touched3.65 on a recent tick. The Tenkan Line or Tenkan Sen (Sen means line in Japanese) is known as the conversion line or turning line is similar to a 9SMA but actually is quite different Continue reading



Source Link(s) Are Here

Chartists Taking Aim at Cancer Genetics Inc (CGIX) Shares - Evergreen Caller

Posted in Cancer Genetics | Comments Off on Chartists Taking Aim at Cancer Genetics Inc (CGIX) Shares – Evergreen Caller

CANCER GENETICS, INC. (NASDAQ:CGIX) Files An 8-K Results of Operations and Financial Condition – Market Exclusive

Posted: at 3:42 am

CANCER GENETICS, INC. Continue reading



Source Link(s) Are Here

CANCER GENETICS, INC. (NASDAQ:CGIX) Files An 8-K Results of Operations and Financial Condition - Market Exclusive

Posted in Cancer Genetics | Comments Off on CANCER GENETICS, INC. (NASDAQ:CGIX) Files An 8-K Results of Operations and Financial Condition – Market Exclusive

What’s Behind Cancer Genetics Inc (CGIX)’s Movement – Stock Rover

Posted: at 3:42 am

Shares ofCancer Genetics Inc (CGIX) aremoving on volatility today6.01% or 0.22 from the open.TheNASDAQ listed companysaw a recent bid of 3.88 and123590shares have traded hands in the session. Coming up with a viable and solid stock investment plan might be on the minds of many individual investors Continue reading



Source Link(s) Are Here

What's Behind Cancer Genetics Inc (CGIX)'s Movement - Stock Rover

Posted in Cancer Genetics | Comments Off on What’s Behind Cancer Genetics Inc (CGIX)’s Movement – Stock Rover

Page 11234..1020..»